胆道癌症的免疫疗法:有效但不够?
Alessandro Rizzo1, Enes Erul2, Deniz Can Guven2
1S.S.D. C.O.r.O. Bed Management Presa in Carico, TDM, IRCCS Istituto Tumori "Giovanni Paolo II", Bari, Italy.
结合免疫治疗的胆道癌症 (BTC) 治疗有希望,但面临阻力. 研究正在探索新的策略,以克服这些挑战,以获得更好的患者结果.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 胆道癌症研究 胆道癌症研究
背景情况:
- 胆道癌 (BTC) 是一种侵袭性的恶性瘤.
- 目前转移性BTC的第一线治疗包括化疗加上免疫检查点抑制剂 (ICI).
- 这些组合只对一小部分患者有好处,很少出现长期反应.
研究的目的:
- 审查现有数据和临床试验,以克服BTC中的ICI耐药性.
- 针对BTC患者接受ICI治疗的初级和获得性耐药机制.
主要方法:
- 关于BTC免疫治疗的当前文献的综述.
- 对正在进行的临床试验进行分析,调查新的组合策略.
- 在BTC中检查抵抗机制和瘤微环境 (TME).
主要成果:
- 化疗和免疫疗法的组合是转移性BTC的标准治疗方法.
- 创新的方法,如双重免疫疗法和ICI与向或局部区域疗法显示协同作用.
- 显著的挑战包括初级/二级耐药性,免疫抑制性BTC TME,以及缺乏反应生物标志物.
结论:
- 尽管取得了进展,但克服耐药性仍然是提高BTC治疗疗效的关键.
- 需要进一步的研究来确定可靠的生物标志物,并制定策略来增强对BTC免疫治疗的反应.
更多相关视频
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
相关概念视频
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
